Upgrade to SI Premium - Free Trial

Seattle Genetics (SGEN) PT Raised to $200 at JMP Securities After Positive ESMO Data and Commentary

September 22, 2020 6:31 AM
JMP Securities analyst Reni Benjamin raised the price target on Seattle Genetics (NASDAQ: SGEN) to $200.00 (from $185.00) after the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change